Aimee J. Lenar, President of US Pharma at Bausch Health Companies Inc., filed a Form 4 on August 20, 2026, disclosing the sale of 36,827 common shares on August 19, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Key Highlights
- Reporting person: Aimee J. Lenar, President, US Pharma at Bausch Health Companies Inc.
- Shares sold: 36,827 common shares disposed of on 08/19/2026 at $7.03 per share.
- Transaction code: S (open-market sale), executed directly by the reporting person.
- Post-transaction ownership: 334,853 common shares beneficially owned directly following the reported sale.
- 10b5-1 plan: The sale was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 21, 2026.
- Filing date: August 20, 2026, signed by Brianna M. Dorsi as attorney-in-fact.
Lenar's Open-Market Sale of Bausch Health Common Shares
According to the Form 4 filed with the SEC on August 20, 2026, Aimee J. Lenar, who serves as President, US Pharma at Bausch Health Companies Inc. (NYSE:BHC), disposed of 36,827 common shares, no par value, on August 19, 2026. The shares were sold at a price of $7.03 each in the open market, as disclosed in Table I of the filing.
The filing indicates that the sale was executed under a Rule 10b5-1 trading plan that the reporting person adopted on May 21, 2026. As the filing notes in its explanation of responses, the transaction "represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 21, 2026." The Form 4 also carries a checked box confirming the transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Following this transaction, the filing reports that Lenar directly holds 334,853 common shares of Bausch Health. No derivative securities transactions were reported in Table II of the filing. The Form 4 was signed by Brianna M. Dorsi as attorney-in-fact on behalf of the reporting person.
What Was Disclosed
The filing disclosed one open-market sale of 36,827 Bausch Health common shares by officer Aimee J. Lenar at $7.03 per share on August 19, 2026, conducted under a Rule 10b5-1 plan adopted May 21, 2026, leaving her with 334,853 shares directly held.





Please wait processing your request...